Hyperhep B 220 Unit

HyperHEP B 220 Unit is a hepatitis B immunoglobulin solution for intramuscular use. It provides passive immunity against hepatitis B virus (HBV) infection. This product is manufactured by Grifols Therapeutics LLC in the United States.

Hepatitis B immunoglobulin (human) is used to prevent hepatitis B virus (HBV) infection. It is often administered to individuals exposed to HBV, such as those who have been accidentally exposed to infected blood or bodily fluids. This solution may also be used for post-exposure prophylaxis in individuals who have not been vaccinated or have not completed the vaccination series.

Common effects of hepatitis B immunoglobulin may include mild pain, swelling, or redness at the injection site. Some individuals may experience temporary discomfort or soreness. Severe reactions are rare but can include allergic responses, which should be reported to a healthcare provider immediately.

Hepatitis B immunoglobulin should be handled with care and stored as per the manufacturer's instructions. It is important to inform healthcare providers of any known allergies or medical conditions before administration. This product should not be used if the solution appears discolored or contains particles.

Hepatitis B immunoglobulin may interact with other medications or vaccines. It is advisable to consult a healthcare provider before using this product in conjunction with other treatments. Alcohol or certain medications may affect the body's response to the immunoglobulin, so it is important to discuss all current medications with a healthcare provider.